RETRACTED: Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21 (International Journal of Immunopathology and Pharmacology, (2018), 32, (205873841881434), 10.1177/2058738418814341);Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21

International Journal of Immunopathology and Pharmacology

Volumn 32, Issue , 2018, Pages

  Zhu, Genglong ^a   Liu, Xialei ^a   Li, Haijing ^a   Yan, Yang ^a   Hong, Xiaopeng ^a   Lin, Zhidong ^a  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

kaempferol; liver cancer; microRNA 21; phosphatase and tensin homologue; PI3K AKT mTOR signaling pathway

Indexed keywords

KAEMPFEROL; KAEMPFEROL DERIVATIVE; MICRORNA; MIRN21 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HEP-G2 CELL LINE; HUMAN; LIVER TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; KAEMPFEROLS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 85057203897     PISSN: 03946320     EISSN: 20587384     Source Type: Journal    
DOI: 10.1177/20587384211040394     Document Type: Erratum

References (39)

1. Siegel RL, Miller KD, Jemal A, (2016) Cancer statistics, 2016. CA: A Cancer Journal for Clinicians 66(1): 7–30.
2. Pan JJ, Javle M, Thinn MM. (2010) Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma. Hepatic Medicine: Evidence and Research 2: 147–155.
3. Poggi G, Pozzi E, Riccardi A. (2010) Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. Anticancer Research 30(12): 5159–5164.
4. Fuji N, Taniguchi H, Amaike H. (2005) Synchronously resected double primary hepatic cancer, hepatocellular carcinoma and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 20(6): 967–969.
5. Golubnitschaja O, Yeghiazaryan K, Stricker H. (2016) Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer 16: 357.
6. Adam R, de Gramont A, Figueras J. (2015) Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus. Cancer Treatment Reviews 41(9): 729–741.
7. Zheng Q, Wu M, (2015) Evaluation of therapeutic effect of contrast-enhanced ultrasonography in hepatic carcinoma radiofrequency ablation and comparison with conventional ultrasonography and enhanced computed tomography. Journal of Medical Ultrasound 23: 76–81.
8. Saito H, Goto T, Inamura K. (2016) Detection of rapidly progressing hepatic angiosarcoma on autopsy that would have definitely been diagnosable on percutaneous liver biopsy. Nihon Shokakibyo Gakkai Zasshi = The Japanese Journal of Gastro-Enterology 113(5): 837–840.
9. Huang YB, Lin MW, Chao Y. (2014) Anti-oxidant activity and attenuation of bladder hyperactivity by the flavonoid compound kaempferol. International Journal of Urology 21(1): 94–98.
10. Yi X, Zuo J, Tan C. (2016) Kaempferol, a flavonoid compound from gynura medica induced apoptosis and growth inhibition in mcf-7 breast cancer cell. African Journal of Traditional Complementary and Alternative Medicines 13(4): 210–215.
11. Garcia-Mediavilla V, Crespo I, Collado PS. (2007) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. European Journal of Pharmacology 557(2–3): 221–229.
12. Zang Y, Sato H, Igarashi K, (2011) Anti-diabetic effects of a kaempferol glycoside-rich fraction from unripe soybean (Edamame, Glycine max L. Merrill. “Jindai”) leaves on KK-A(y) mice. Bioscience Biotechnology and Biochemistry 75(9): 1677–1684.
13. An M, Kim M, (2015) Protective effects of kaempferol against cardiac sinus node dysfunction via CaMKII deoxidization. Anatomy & Cell Biology 48(4): 235–243.
14. Guo H, Lin W, Zhang X. (2017) Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway. Oncotarget 8(47): 82207–82216.
15. Mylonis I, Lakka A, Tsakalof A. (2010) The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochemical and Biophysical Research Communications 398(1): 74–78.
16. Betel D, Wilson M, Gabow A. (2008) The microRNA.org resource: Targets and expression. Nucleic Acids Research 36: D149–D153.
17. Pan X, Wang ZX, Wang R, (2010) MicroRNA-21: A novel therapeutic target in human cancer. Cancer Biology & Therapy 10(12): 1224–1232
18. Pineau P, Volinia S, McJunkin K. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 107(1): 264–269.
19. Zhu Q, Wang Z, Hu Y. (2012) miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncology Reports 27(5): 1660–1668.
20. Meng F, Henson R, Wehbe-Janek H. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2): 647–658.
21. Kim K, Kim S, Moh SH. (2015) Kaempferol inhibits vascular smooth muscle cell migration by modulating BMP-mediated miR-21 expression. Molecular and Cellular Biochemistry 407(1–2): 143–149.
22. Ish-Shalom S, Lichter A, (2010) Analysis of fungal gene expression by real time quantitative PCR. Methods in Molecular Biology 638: 103–114.
23. Mao QD, Zhang W, Zhao K. (2017) MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer. Brazilian Journal of Medical and Biological Research 50(6): e6103.
24. Herrera I, Cisneros J, Maldonado M. (2013) Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption. The Journal of Biological Chemistry 288(36): 25964–25975.
25. Sutoh Yoneyama M, Hatakeyama S, Habuchi T. (2014) Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis. European Journal of Cell Biology 93(4): 157–169.
26. Savic LJ, Chapiro J, Duwe G. (2016) Targeting glucose metabolism in cancer: New class of agents for loco-regional and systemic therapy of liver cancer and beyond? Hepatic Oncology 3(1): 19–28.
27. Yan H, Wang X, Niu J. (2014) Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells. PLoS ONE 9(4): e95609.
28. Ozcan C, Yaman M, (2013) Determination of kaempferol in Rosa canina, Urtica dioica, Terebinthina chica and Portulace oleracea by HPLC-MS. Asian Journal of Chemistry 25: 9758–9762.
29. Mukhopadhyay A, Banerjee S, Stafford LJ. (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21(57): 8852–8861.
30. Elmore S, (2007) Apoptosis: A review of programmed cell death. Toxicologic Pathology 35(4): 495–516.
31. Cimmino A, Calin GA, Fabbri M. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America 102(39): 13944–13949.
32. Kulkarni V, Naqvi AR, Uttamani JR. (2016) MiRNA-target interaction reveals cell-specific post-transcriptional regulation in mammalian cell lines. International Journal of Molecular Sciences 17(1): 72.
33. Hong M, Wang N, Tan HY. (2015) MicroRNAs and Chinese medicinal herbs: New possibilities in cancer therapy. Cancers 7(3): 1643–1657.
34. Peng C, Chen Y, Yang Z. (2010) PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice. Blood 115(3): 626–635.
35. Wu Z, He Y, Li D. (2017) Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21. American Journal of Translational Research 9(7): 3326–3335.
36. Zhang BG, Li JF, Yu BQ. (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncology Reports 27(4): 1019–1026.
37. Kashafi E, Moradzadeh M, Mohamadkhani A. (2017) Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomedicine Pharmacotherapy 89: 573–577.
38. Gwak HS, Kim TH, Jo GH. (2012) Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS ONE 7(10): e47449.
39. Tang H, Li RP, Liang P. (2015) miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncology Letters 10(2): 681–686.